LONDON--(BUSINESS WIRE)-- Market Publishers Ltd informs that new in-demand La Merie research reports have been added to its catalogue.
Competitor Analysis: Coagulation Factors. The study provides a competitor evaluation in the field of plasma-derived and recombinant coagulation factors for topical or systemic administration to treat hereditary or acquired coagulation disorders as of January 2011. The report includes a compilation of current active projects in research and development of topical and systemic coagulation factors obtained by purification of human plasma or by recombinant DNA technology. In addition, the report lists company-specific R&D pipelines of coagulation factors … http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/competitor_analysis_coagulation_factors.html
Competitor Analysis: Erythropoietin (EPO). The analysis provides information on existing first and second generation epoetin products in regulated markets, an overview on biosimilar versions of EPO in regulated markets, a compilation of novel, next generation Erythropoiesis Stimulating Agents (ESAs) separately for biologics and for oral small molecules and a summary of first generation EPO products as well as of darbepoietin biosimilar versions in less regulated markets. The report includes a compilation of currently marketed EPO and ESA products and active EPO and ESA projects in research and development. The research also lists company-specific product portfolios and R&D pipelines … http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/competitor_analysis_erythropoietin_epo.html
Competitor Analysis: Insulin. The study provides a competitor analysis in the development pipeline of novel insulin-based products for treatment of type 1 and 2 diabetes. The report includes a compilation of current active projects in research and development of novel insulin-based products. In addition, the research lists company-specific product portfolios and R&D pipelines of insulin, insulin analogs and new delivery forms of insulin on the market or in R&D … http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/competitor_analysis_insulin.html
Competitor Analysis: Thrombolytics & Fibrinolytics. The study provides a competitor analysis in the development pipeline of novel thrombolytics and fibrinolytics for treatment of cardiovascular thrombosis, stroke and eye diseases. The report provides information on the various generation of marketed thrombolytics and includes a compilation of current active projects in research and development of novel thrombolytics and fibrinolytics including those in development in ophthalmology and in less regulated markets. In addition, the report lists company-specific product portfolios and R&D pipelines of thrombolytics and fibrinolytics … http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/competitor_analysis_thrombolytics_fibrinolytics.html
More new reports by La Merie can be found at http://marketpublishers.com/members/la_merie/info.html
CONTACT:
The Market Publishers, Ltd.
Mrs. Alla Martin
Tel: +44 208 123 2220
Fax: +44 207 900 3970
[email protected]
www.marketpublishers.com
KEYWORDS: United Kingdom Europe
INDUSTRY KEYWORDS: Health Biotechnology Medical Devices Pharmaceutical
MEDIA:
| Logo |